127 related articles for article (PubMed ID: 1937996)
1. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
[TBL] [Abstract][Full Text] [Related]
2. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients.
Forst H; Ruckdeschel G; Unertl K; Dieterich HJ; Ehret W; Sunder-Plassmann L
Arzneimittelforschung; 1989 May; 39(5):618-9. PubMed ID: 2757681
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
Mengozzi G; Intorre L; Bertini S; Soldani G
Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
[TBL] [Abstract][Full Text] [Related]
4. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
[TBL] [Abstract][Full Text] [Related]
5. Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.
Rohwedder R; Bergan T; Caruso E; Thorsteinsson SB; Della Torre H; Scholl H
Chemotherapy; 1991; 37(4):229-38. PubMed ID: 1790720
[TBL] [Abstract][Full Text] [Related]
6. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.
Boothe DM; Boeckh A; Boothe HW; Wilkie S
Vet Ther; 2001; 2(2):120-8. PubMed ID: 19753704
[TBL] [Abstract][Full Text] [Related]
7. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM
Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and milk penetration of difloxacin after intravenous, subcutaneous and intramuscular administration to lactating goats.
Marín P; Escudero E; Fernández-Varón E; Cárceles CM
J Vet Pharmacol Ther; 2007 Feb; 30(1):74-9. PubMed ID: 17217405
[TBL] [Abstract][Full Text] [Related]
13. Penetration of ciprofloxacin and its desethylenemetabolite into skin in humans after a single oral dose of the parent drug assessed by cutaneous microdialysis.
Bielecka-Grzela S; Klimowicz A
J Clin Pharm Ther; 2005 Aug; 30(4):383-90. PubMed ID: 15985052
[TBL] [Abstract][Full Text] [Related]
14. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
Friis C
Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371
[TBL] [Abstract][Full Text] [Related]
15. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
[TBL] [Abstract][Full Text] [Related]
17. Disposition kinetics of danofloxacin and ciprofloxacin in broiler chickens.
el-Gendi AY; el-Banna HA; Abo Norag M; Gaber M
Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):429-34. PubMed ID: 11721591
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
Davis JL; Foster DM; Papich MG
J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
[TBL] [Abstract][Full Text] [Related]
19. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
[TBL] [Abstract][Full Text] [Related]
20. Penetration of ciprofloxacin into human lung tissue after oral and i.v. dosing.
Caruso E; Castro JM; Chamoles N; Galimberti R; Jorge L; Rohwedder R
J Chemother; 1989 Jul; 1(4 Suppl):549-51. PubMed ID: 16312527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
